Olivier Brandicourt - Net Worth and Insider Trading

Olivier Brandicourt Net Worth

The estimated net worth of Olivier Brandicourt is at least $5 Million dollars as of 2024-04-26. Olivier Brandicourt is the Business Unit President of Pfizer Inc and owns about 202,260 shares of Pfizer Inc (PFE) stock worth over $5 Million. Details can be seen in Olivier Brandicourt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Olivier Brandicourt has not made any transactions after 2013-03-06 and currently still holds the listed stock(s).

Transaction Summary of Olivier Brandicourt

To

Olivier Brandicourt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Olivier Brandicourt owns 2 companies in total, including Alnylam Pharmaceuticals Inc (ALNY) , and Pfizer Inc (PFE) .

Click here to see the complete history of Olivier Brandicourt’s form 4 insider trades.

Insider Ownership Summary of Olivier Brandicourt

Ticker Comapny Transaction Date Type of Owner
ALNY Alnylam Pharmaceuticals Inc 2020-03-02 director
PFE Pfizer Inc 2013-03-06 Business Unit President

Olivier Brandicourt Latest Holdings Summary

Olivier Brandicourt currently owns a total of 1 stock. Olivier Brandicourt owns 202,260 shares of Pfizer Inc (PFE) as of March 6, 2013, with a value of $5 Million.

Latest Holdings of Olivier Brandicourt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PFE Pfizer Inc 2013-03-06 202,260 25.26 5,109,088

Holding Weightings of Olivier Brandicourt


Olivier Brandicourt Form 4 Trading Tracker

According to the SEC Form 4 filings, Olivier Brandicourt has made a total of 0 transactions in Pfizer Inc (PFE) over the past 5 years. The most-recent trade in Pfizer Inc is the sale of 113,364 shares on March 6, 2013, which brought Olivier Brandicourt around $3 Million.

Insider Trading History of Olivier Brandicourt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Olivier Brandicourt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Olivier Brandicourt Ownership Network

Ownership Network List of Olivier Brandicourt

No Data

Ownership Network Relation of Olivier Brandicourt


Olivier Brandicourt Owned Company Details

What does Alnylam Pharmaceuticals Inc do?

Who are the key executives at Alnylam Pharmaceuticals Inc?

Olivier Brandicourt is the director of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Tolga Tanguler , CMO & EVP Dev & Med Affairs Pushkal Garg , and EVP & CLO & Secretary Indrani Lall Franchini .

Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary

Over the past 18 months, Olivier Brandicourt made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 30,567 shares made by Pushkal Garg , a net sale of 7,095 shares made by Indrani Lall Franchini , and a net sale of 14,604 shares made by Yvonne Greenstreet .

In summary, during the past 3 months, insiders sold 36,501 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 36,501 shares. During the past 18 months, 159,676 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,676 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alnylam Pharmaceuticals Inc Insider Transactions

No Available Data

Olivier Brandicourt Mailing Address

Above is the net worth, insider trading, and ownership report for Olivier Brandicourt. You might contact Olivier Brandicourt via mailing address: Pfizer Inc. Attn. Corp. Secretary, 235 East 42nd Street, New York Ny 10017.

Discussions on Olivier Brandicourt

No discussions yet.